Similarly, mRNA for the somatostatin receptors, SSTR1 (P < 0.01) and SSTR2 (P < 0.001), which are associated with somatostatin analogue therapy, were differentially expressed across all tumor samples. This evidence concerns the gene SSTR2 and neoplasm.